PMID- 17895999 OWN - NLM STAT- MEDLINE DCOM- 20080924 LR - 20220129 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 2 IP - 9 DP - 2007 Sep 26 TI - The INT6 cancer gene and MEK signaling pathways converge during zebrafish development. PG - e959 LID - e959 AB - BACKGROUND: Int-6 (integration site 6) was identified as an oncogene in a screen of tumorigenic mouse mammary tumor virus (MMTV) insertions. INT6 expression is altered in human cancers, but the precise role of disrupted INT6 in tumorigenesis remains unclear, and an animal model to study Int-6 physiological function has been lacking. PRINCIPAL FINDINGS: Here, we create an in vivo model of Int6 function in zebrafish, and through genetic and chemical-genetic approaches implicate Int6 as a tissue-specific modulator of MEK-ERK signaling. We find that Int6 is required for normal expression of MEK1 protein in human cells, and for Erk signaling in zebrafish embryos. Loss of either Int6 or Mek signaling causes defects in craniofacial development, and Int6 and Erk-signaling have overlapping domains of tissue expression. SIGNIFICANCE: Our results provide new insight into the physiological role of vertebrate Int6, and have implications for the treatment of human tumors displaying altered INT6 expression. FAU - Grzmil, Michal AU - Grzmil M AD - Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom. FAU - Whiting, Danny AU - Whiting D FAU - Maule, John AU - Maule J FAU - Anastasaki, Corina AU - Anastasaki C FAU - Amatruda, James F AU - Amatruda JF FAU - Kelsh, Robert N AU - Kelsh RN FAU - Norbury, Chris J AU - Norbury CJ FAU - Patton, E Elizabeth AU - Patton EE LA - eng GR - A7791/CRUK_/Cancer Research UK/United Kingdom GR - G120/875/MRC_/Medical Research Council/United Kingdom GR - MC_PC_U127585840/MRC_/Medical Research Council/United Kingdom GR - MC_U127585840/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070926 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Eukaryotic Initiation Factor-3) RN - 0 (RNA, Messenger) RN - 0 (RNA, Small Interfering) RN - 0 (Zebrafish Proteins) RN - EC 2.7.12.2 (MAP Kinase Kinase 1) RN - EC 2.7.12.2 (MAP2K1 protein, human) SB - IM MH - Animals MH - Cell Line, Tumor MH - Eukaryotic Initiation Factor-3/*genetics/physiology MH - Humans MH - Immunoblotting MH - MAP Kinase Kinase 1/genetics/metabolism MH - MAP Kinase Signaling System/*genetics/physiology MH - RNA, Messenger/genetics/metabolism MH - RNA, Small Interfering/genetics MH - Reverse Transcriptase Polymerase Chain Reaction MH - Zebrafish/embryology/*genetics/growth & development MH - Zebrafish Proteins/*genetics/physiology PMC - PMC1978538 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2007/09/27 09:00 MHDA- 2008/09/25 09:00 PMCR- 2007/09/26 CRDT- 2007/09/27 09:00 PHST- 2007/08/03 00:00 [received] PHST- 2007/09/02 00:00 [accepted] PHST- 2007/09/27 09:00 [pubmed] PHST- 2008/09/25 09:00 [medline] PHST- 2007/09/27 09:00 [entrez] PHST- 2007/09/26 00:00 [pmc-release] AID - 07-PONE-RA-01926R1 [pii] AID - 10.1371/journal.pone.0000959 [doi] PST - epublish SO - PLoS One. 2007 Sep 26;2(9):e959. doi: 10.1371/journal.pone.0000959.